Eric Van Cutsem
- Oncology top 0.01%
- Colorectal Cancer Treatments and Studies 710
- Cancer Treatment and Pharmacology 230
- Pancreatic and Hepatic Oncology Research 160
- Hepatology top 0.01%
- Hepatocellular Carcinoma Treatment and Prognosis 111
- Gastroenterology top 0.02%
- Pulmonary and Respiratory Medicine top 0.01%
- Gastric Cancer Management and Outcomes 384
- Lung Cancer Treatments and Mutations 170
- Pathology and Forensic Medicine top 0.01%
- Genetic factors in colorectal cancer 166
-
- Cancer Genomics and Diagnostics 135
- Co-authors
- Josep TaberneroSalvatore SienaDavid CunninghamMarc PeetersYves HumbletPhilippe RougierBernard NordlingerAtsushi Ohtsu
- Cited by
- OncologyHepatologyGastroenterology
- Journals
- Journal of Clinical Oncology (450 papers)Annals of Oncology (247 papers)European Journal of Cancer (66 papers)
- Partner nations
- BelgiumUnited StatesSpain
In The Last Decade
Eric Van Cutsem
1.2k papers receiving 93.2k citations
Hit Papers
Peers
Comparison fields: 5 of 180
- Oncology 70.1k
- Hepatology 14.3k
- Gastroenterology 6.4k
- Pulmonary and Respiratory Medicine 36.0k
- Pathology and Forensic Medicine 16.2k
Countries citing papers authored by Eric Van Cutsem
This map shows the geographic impact of Eric Van Cutsem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Van Cutsem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Van Cutsem more than expected).
Fields of papers citing papers by Eric Van Cutsem
This network shows the impact of papers produced by Eric Van Cutsem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Van Cutsem. The network helps show where Eric Van Cutsem may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eric Van Cutsem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Studybreakdown → | 2021 | 331 |
| 3 | Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancerbreakdown → | 2019 | 1468 |
| 4 | 2016 | 192 | |
| 5 | 2015 | 58 | |
| 6 | Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and RAS Mutations in Colorectal Cancerbreakdown → | 2015 | 578 |
| 7 | 2014 | 92 | |
| 8 | 2014 | 257 | |
| 9 | 2013 | 69 | |
| 10 | 2013 | 157 | |
| 11 | 2013 | 185 | |
| 12 | 2012 | 358 | |
| 13 | 2012 | 163 | |
| 14 | Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimenbreakdown → | 2012 | 986 |
| 15 | 2012 | 94 | |
| 16 | Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancerbreakdown → | 2011 | 533 |
| 17 | Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancerbreakdown → | 2010 | 755 |
| 18 | Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trialbreakdown → | 2009 | 487 |
| 19 | 2009 | 241 | |
| 20 | Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancerbreakdown → | 2008 | 2400 |
About Eric Van Cutsem
Eric Van Cutsem is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology, having authored 1.2k papers that have together received 95.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (710 papers), Gastric Cancer Management and Outcomes (384 papers), Cancer Treatment and Pharmacology (230 papers), Lung Cancer Treatments and Mutations (170 papers), Genetic factors in colorectal cancer (166 papers), Pancreatic and Hepatic Oncology Research (160 papers), Cancer Genomics and Diagnostics (135 papers) and Hepatocellular Carcinoma Treatment and Prognosis (111 papers). The work is most often cited by research in Oncology (70.1k citations), Hepatology (14.3k citations) and Gastroenterology (6.4k citations). Eric Van Cutsem has collaborated with scholars based in Belgium, United States and Spain. Frequent co-authors include Josep Tabernero, Salvatore Siena, David Cunningham, Marc Peeters, Yves Humblet, Philippe Rougier, Bernard Nordlinger, Atsushi Ohtsu, Chris Verslype and Yung‐Jue Bang. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, ESMO Open and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.